An interventional study of Corticosteroid injection + Trigger Splint+ Education and Home exercises and Corticosteroid injection in Trigger Finger and Stenosing Tenosynovitis, sponsored by The Philadelphia & South Jersey Hand Center. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-18.
Sponsored by The Philadelphia & South Jersey Hand Center · Not applicable, Interventional, and Treatment
Among 35 studies in Trigger Finger Disorder with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Trigger Finger Disorder · United States.
Among the 35 studies in Trigger Finger Disorder with a site in United States, this one is the 14th largest by planned enrollment of the 30 interventional ones, is the only one that started in 2013, is one of 18 with no phase, and was the 4th registered.
93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.
This study's planned enrollment of 100 is above the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.
Browse Trigger Finger Disorder studies →6 of the 35 studies in Trigger Finger Disorder with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 11 Trigger Finger Disorder studies recruiting now, 7 (64%) set no upper age limit and 3 (27%) stop at 75 or younger; 0 take children under 18; 1 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →35 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2013.
Median enrollment 88 across the 30 interventional studies, 86 across the 5 observational. Of the 23 that completed or were terminated, 9 (39%) have results posted.
None of the 35 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with The Philadelphia & South Jersey Hand Center as lead sponsor.
The Philadelphia & South Jersey Hand Center has 1 study filed under Trigger Finger Disorder — fewer than ten, so there is no comparison to draw.
4 of the studies in Trigger Finger Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07227649University of ArizonaNAC-REPAIR for Post-surgical Pain | 2027-01-15 |
| NCT07158892University of Texas at AustinUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | 2027-01-20 |
| NCT07516652Washington University School of MedicineProspective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release | 2027-04-01 |
| NCT05292339Emory UniversityKetorolac in Upper Extremity Tendinopathy and Arthropathy | 2027-07 |
Among the 35 studies in Trigger Finger Disorder with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
Hypothesis: Treatment of trigger finger by corticosteroid injection and splinting is superior to corticosteroid treatment alone.
Stenosing tenosynovitis, or more commonly "trigger finger" is a disease that can severely impact a patient's quality of life. Its incidence is said to be 28 persons per 100,000 annually. The disease is manifested in one or more fingers by finger locking in flexion or extension, leading to pain, discomfort and at times, loss of function. Patients frequently report having to snap their fingers back in position to alleviate symptoms. The pathophysiology relates to thickening of the flexor tendon sheath, which can impair tendon gliding within it.
Although multiple treatment strategies are available, it is not entirely clear which treatment offers the best outcome, especially when the finger has not reached end stage locking. In general, corticosteroid injection into the tendon sheath is offered as the first line of treatment. Splinting alone has also been described as a reliable method treatment. However, Patel and Bassini indicated that steroid injection results in fewer recurrences than splinting alone. Surgery is typically reserved for recurrent triggering, cases refractory to injection, or digits locked in flexion. The effects of steroid injection followed by splinting however have not been reported in a comprehensive fashion. It may be that this form of treatment could result in a synergistic effect, which can offer a treatment modality superior to either injection or splinting alone. The purpose of this research study is to determine whether steroid injection followed by splinting is superior to injection alone.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard corticosteroid injection.
Procedure: Corticosteroid injection
Corticosteroid Injection + Trigger Splint + Education + Home Exercises
Procedure: Corticosteroid injection + Trigger Splint+ Education and Home exercises
Standard corticosteroid injection. Hand based, single digit trigger splint will be applied. Education and instructions about home exercises.
Standard trigger finger corticosteroid injection.
Stage of finger triggering
Trigger Finger Stage: 1. Normal 2. Painful palpable nodule 3. Triggering = Clicking = Catching 4. Locking of finger in flexion or extension unlocked by active finger movement 5. Locking of finger in flexion or extension unlocked by passive finger movement 6. Locked finger in flexion or extension (Each stage may be painless or painful)
Time frame: 1, 2, 4-6, and 12 months
Failed treatment: surgical intervention required
Failed treatment OR Successful treatment
Time frame: 1,2, 4-6, 12months
Patient rated functional outcome
Quick Disabilities of the Arm, Shoulder and Hand questionnaire Patient Specific Functional Scale
Time frame: 1, 2, 4-6, 12months
Pain
Visual Analog Scale
Time frame: 1, 2, 4-6, 12 months
Compliance with splint and hand exercises
For patients who are assigned to injection and splint group, home exercise and splint compliance will be assessed by patients maintaining a case log.
Time frame: 1, 2 months
The record gives a start of May 2013, a primary completion of Dec 2015 and a completion of May 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.